KLINISKA PRÖVNINGAR - OBLIGATORISK LITTERATUR

• WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects, World Medical Association, https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/Obligatorisk*
• ICH Topic E3: Structure and Content och Clinical Study Reports, EMA, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002832.pdfObligatorisk*
• ICH Topic E4: Dose-Response Information to Support Drug Registration, EMA, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002834.pdfObligatorisk*
• ICH Topic E6: Guideline for Good Clinical Practice, EMA, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdfObligatorisk*
• ICH Topic E8: General Considerations for Clinical Trials, EMA, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002877.pdfObligatorisk*
• ICH topic E9: Statistical Principles for Clinical Trials, EMA, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002928.pdfObligatorisk*
• ICH topic E10: Choice of Control Group and Related Issues in Clinical Trials, EMA, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002925.pdfObligatorisk*
• REGULATION No 536/2014 of the European Parliament and of the Council on clinical trials on medicinal products for human use, repealing Directive 2001/20/EC., EU, http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1497947926249&uri=CELEX:32014R0536Obligatorisk*
• DIRECTIVE 2001/20/E, laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use, EU, https://ec.europa.eu/health/human-use/clinical-trials/directive_enObligatorisk*
• 2011/C 172/01: Communication from the Commission - Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human use (CT-3), EU, http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1497948126522&uri=CELEX:52011XC0611(01)Obligatorisk*
• Consort 2010 Checklist, Explanations and Elaboration document, The CONSORT Group, 2010, CONSORT hemsidaObligatorisk* (Klicka på fliken CONSORT 2010 -> CONSORT Checklist för en lättnavigerad webbversion av checklistan med förklaringar.)
• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials, BMJ, 2010, Artikel med checklista, förklaringar och bakgrund (open access)Obligatorisk*

KLINISKA PRÖVNINGAR - REKOMMENDERAD LITTERATUR

• Friedman, Lawrence M. m.fl., Fundamentals of Clinical Trials, 5th ed. 2015., Cham, Springer International Publishing, 2015
• Friedman, Lawrence M.; Furberg, Curt C.; DeMets, David L., Fundamentals of clinical trials, 4. ed., New York, Springer, cop. 2010
• Sundström, Johan; Lind, Lars, Handbok i biomedicinsk forskning, Första upplagan, Stockholm, Liber, [2015]
• Lemne, Carola; Lafolie, Pierre, Handbok för kliniska prövare, 6:1, Studentlitteratur, 2009
• Läkemedelsverket, Läkemedelsverkets föreskrifter (LVFS 2011:19) om kliniska läkemedelsprövningar på människor, Institutionen för medicinska vetenskaper, 2016, Läkemedelsverkets föreskrifter (LVFS 2011:19) om kliniska läkemedelsprövningar på människor (länk till föreskrifter och vägledning)
• Anehus, Siw m.fl., Handbok i genomförande av en klinisk prövning: praktisk tillämpning av lagar och regler med fokus på monitering, 1. uppl., Lund, Studentlitteratur AB, 2012

STATISTIK - REKOMMENDERAD LITTERATUR

• Machin, David; Campbell, Michael J.; Walters, Stephen John, Medical statistics: a textbook for the health sciences, 4th ed., Chichester, Wiley, 2007
• Bring, Johan; Taube, Adam, Introduktion till medicinsk statistik, Lund, Studentlitteratur, 2006
• Körner, Svante; Wahlgren, Lars, Statistisk dataanalys, 5. uppl., Lund, Studentlitteratur, 2015 (eller tidigare upplaga)
• CPMP/EWP/908/99: POINTS TO CONSIDER ON MULTIPLICITY ISSUES IN CLINICAL TRIALS, EMA, European Medicines Agency, http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003640.pdf
• EMA/CPMP/EWP/1776/99 Rev. 1: Guideline on Missing Data in Confirmatory Clinical Trials, EMA, European Medicines Agency, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/09/WC500096793.pdf
• CPMP/EWP/482/99: POINTS TO CONSIDER ON SWITCHING BETWEEN SUPERIORITY AND NON-INFERIORITY, EMA, European Medicines Agency, http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003658.pdf
• HK, Ramakrishna., Medical Statistics: For Beginners, Singapore, Springer Singapore, 2017 (https://link-springer-com.ezproxy.its.uu.se/book/10.1007%2F978–981-10–1923-4#about)

FARMAKOKINETIK - REKOMMENDERAD LITTERATUR

• Birkett, D. J., Pocket guide: pharmacokinetics made easy, 2nd ed., North Ryde, N.S.W., McGraw-Hill Australia, 2010

* Obligatorisk